Unilateral carpal tunnel syndrome; Near death experience; Pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of CARPAL TUNNEL SYNDROME (Unilateral carpal tunnel syndrome), NEAR DEATH EXPERIENCE (Near death experience) and PNEUMONIA (Pneumonia) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    The patient had no known allergies and had no relevant medical history.  The patient's past medical history included Carpal tunnel release (right wrist carpal tunnel surgery) on 06-Jul-2022.   On 23-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced CARPAL TUNNEL SYNDROME (Unilateral carpal tunnel syndrome) (seriousness criteria hospitalization and medically significant), NEAR DEATH EXPERIENCE (Near death experience) (seriousness criteria hospitalization and medically significant) and PNEUMONIA (Pneumonia) (seriousness criteria hospitalization and medically significant). At the time of the report, CARPAL TUNNEL SYNDROME (Unilateral carpal tunnel syndrome), NEAR DEATH EXPERIENCE (Near death experience) and PNEUMONIA (Pneumonia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided  It was reported on unknown dates, the patient experienced right wrist carpal tunnel, pneumonia, near death experience and bad reaction Moderna covid-19 injection.  On 06-Jul-2022, the patient had right wrist carpal tunnel surgery. The patient was healing from carpal tunnel surgery of right hand. The patient was working from home and was only able to perform four hours of work. The patient also had pneumonia for 12 weeks near death experience.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Reporter causality for the events of unilateral carpal tunnel syndrome,  near death experience and pneumonia with Humira was not reported and causality as per Manufacturer for the events of unilateral carpal tunnel syndrome, near death experience was reported as no reasonable possibility and pneumonia was reported as not assessable.  No treatment medication information provided.  Company Comment: This is a spontaneous case concerning a 51-year-old female patient with no relevant medical history, who experienced the unexpected, serious, events of Carpal Tunnel Syndrome, Pneumonia and Near-Death Experience which were medically significant and led to the hospitalization of the patient and occurred on an unknown date after receiving a dose of mRNA-1273 Vaccine. Approximately 6 months after receiving the third dose of the mRNA-1273 vaccine, patient underwent right wrist carpal tunnel surgery and was healing from the surgery. She was working from home and was only able to perform four hours of work. The patient also had pneumonia for 12 weeks and near death experience, no further information on risk factors, co morbidities, clinical course and management of the events was available in the report. It was reported that the outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 51-year-old female patient with no relevant medical history, who experienced the unexpected, serious, events of Carpal Tunnel Syndrome, Pneumonia and Near-Death Experience which were medically significant and led to the hospitalization of the patient and occurred on an unknown date after receiving a dose of mRNA-1273 Vaccine. Approximately 6 months after receiving the third dose of the mRNA-1273 vaccine, patient underwent right wrist carpal tunnel surgery and was healing from the surgery. She was working from home and was only able to perform four hours of work. The patient also had pneumonia for 12 weeks and near death experience, no further information on risk factors, co morbidities, clinical course and management of the events was available in the report. It was reported that the outcome of the events was unknown. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.